Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome

Author：                          

Publisher： Spandidos Publications

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.30, Iss.1, 2012-01, pp. : 185-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What Is the Best Choice for Combination Therapy in the Management of Dyslipidemia of Metabolic Syndrome?

By  

Cardiology, Vol. 105, Iss. 3, 2006-04 ,pp. : 139-140

Karger

Access to resources Recommend Favorite

Improved genetic counseling in Alport syndrome by new variants of COL4A5 gene

By  

NEPHROLOGY, Vol. 20, Iss. 7, 2015-07 ,pp. : 502-505

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study

By        

International Journal of Molecular Medicine, Vol. 35, Iss. 5, 2015-01 ,pp. : 1290-1300

Spandidos Publications

Access to resources Recommend Favorite

Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 122, Iss. 3, 2018-03 ,pp. : 341-345

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of CCR5 and SDF‐1 genetic variants and HIV infection in Indian population

By  

INTERNATIONAL JOURNAL OF IMMUNOGENETICS, Vol. 42, Iss. 4, 2015-08 ,pp. : 270-278

John Wiley & Sons Inc

Access to resources Recommend Favorite